Ser78
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.8
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser78  -  STX4 (human)

Site Information
AtPLPEEsMkQELQN   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 1172732400

In vivo Characterization
Methods used to characterize site in vivo:
mutation of modification site ( 1 ) , western blotting ( 1 )
Disease tissue studied:
glioblastoma multiforme ( 1 ) , glioma ( 1 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Treatments:
cAMP_analog ( 1 ) , KT5823 ( 1 )

Downstream Regulation
Effects of modification on STX4:
protein degradation ( 1 ) , ubiquitination ( 1 )

References 

1

Perrotta C, et al. (2018) Nitric Oxide Generated by Tumor-Associated Macrophages Is Responsible for Cancer Resistance to Cisplatin and Correlated With Syntaxin 4 and Acid Sphingomyelinase Inhibition. Front Immunol 9, 1186
29896202   Curated Info